Jennifer Kayden Lee

EVP, Head of North America

Jennifer Kayden Lee (EVP, Head of North America) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Rhythm Pharmaceuticals, Inc. (RYTM). The largest single filing was $8.9M of RYTM (75,834 sh × $117.38, as filed), executed Aug 13.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$8.9M

shares × price, as filed

Last traded

Aug 13

Filed Aug 14

Median ADV $88.9M across their filed names

Open performance→

Volume by month

Buys $0 Sells $13.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

RYTM Rhythm Pharmaceuticals, Inc. RYTM · 0 buys · 5 sells 5 filings

Recent filings

RYTMSALE Rhythm Pharmaceuticals, Inc. View filing → $8.9M
75,834 sh × $117.38
Exec Aug 13
Filed Aug 14 · 7:04 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. View filing → $116K
2,035 sh × $57.22
Exec Feb 19 2025
Filed Feb 19 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. View filing → $247K
4,189 sh across 2 lots
Exec Feb 10 2025
Filed Feb 11 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. View filing → $104K
1,733 sh × $60.08
Exec Feb 5 2025
Filed Feb 7 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. View filing → $4.4M
66,661 sh across 3 lots
Exec Nov 11 2024
Filed Nov 13 2024 · 5:30 PM ET